http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#Head http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#assertion http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#provenance http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#pubinfo http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#assertion http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:98262 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_33697 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/UBERON_0004535 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_1 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/decreases http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/Pravastatin http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#assertion http://www.w3.org/2000/01/rdf-schema#label a(SCHEM:Pravastatin) -| r(MGI:Ccl5) http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_5 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_3 http://purl.org/dc/elements/1.1/identifier AHA Abstracts 84 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_3 http://purl.org/dc/elements/1.1/title AHA Abstracts 84 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_3 http://purl.org/dc/elements/1.1/type Other http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_4 http://www.w3.org/ns/prov#value Atherosclerosis is a chronic immuno-inflammatory disease involving the recruitment of monocyte and T lymphocytes. Statins (HMG CoA reductase inhibitors) have proven their beneficial effects on reducing total and low-density lipoprotein (LDL) cholesterol. Recent in vitro and in vivo studies have suggested that statins also have anti-inflammatory properties beyond their lipid lowering effects, involving isoprenoid intermediates such as farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP). Chemokines and their receptors are known to induce leukocytes migration, and recently have been implicated in atherogenesis. To investigate whether statins could reduce the expression of chemokines and chemokine/receptors expression in vivo, we used male LDLR-/- mice fed with a high-cholesterol diet treated or not with pravastatin (10 mg/kg/d) through drinking water. We demonstrate here that the expression of the chemokines RANTES, MCP-1 and IP-10 as well as the chemokine/receptors CCR1, CCR2 and CCR5 were downregulated within atherosclerotic vascular tissue in the statin-treated mice compared to controls. To confirm these findings, we performed in vitro experiments on vascular human smooth muscle cells and endothelial cells. Western Blot, ELISA and RPAs revealed that statins markedly decreased chemokines and chemokine/receptors expression. These effects could be reversed by mevalonate, GGPP and FPP. Inhibition of the GGPP prenylation pathway by GTI confirmed that synthesis of chemokines and their receptors might be mainly Rho dependent. These in vitro and in vivo results clearly indicate that statins have anti-inflammatory properties beyond their lipid effects, which might help to better understand their great clinical benefice in preventing cardiovascular diseases. http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_4 http://www.w3.org/ns/prov#wasQuotedFrom http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_3 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_5 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_3 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#_4 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A#pubinfo http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://purl.org/dc/terms/created 2014-07-03T14:31:26.961+02:00 http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAa2HLJhShmEvyqyKiGIFnOJ3e6Hl07GrtCRJf8zIjb6A http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234